Organization Profile

You just read:

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® and Checkpoint Inhibitor Combination Preclinical Data at AACR Tumor Immunology and Immunotherapy Conference

News provided by

Oncolytics Biotech Inc.

Dec 04, 2014, 06:30 ET